Marlet Property Group chief executive Pat Crean has told the High Court he was “committed” to the €37.6 million purchase of a 9.6-acre site from Dublin City University (DCU).
He refuted the suggestion by DCU’s senior counsel on Thursday that Atlas Limited Partnership, a Marlet subsidiary, wanted to “get out of the deal” when the property market paused during the early stage of the pandemic.
Atlas is suing DCU seeking the return of a €3.76 million deposit it paid as part of a failed deal to buy the site at Hampstead, Glasnevin. The developer also wants the court to declare that the university was unable and unwilling to deliver title of the site.
DCU denies the claims, saying it at all times could sell the land but Atlas was in breach of the December 2019 sale contract by failing to complete the purchase.
Ceann comhairle election key task as 34th Dáil convenes for first time
Your EV questions answered: Am I better to drive my 13-year-old diesel until it dies than buy a new EV?
Workplace wrangles: Staying on the right side of your HR department, and more labrynthine aspects of employment law
The great trifle revival: ‘Two creamy, delicious things on top of a boozy, fruity, delicious thing’ - what’s not to like?
Central to the case are alleged title or “mapping” issues relating to a small portion of land Atlas has described as “critical” for the development team to access the site and whether DCU was able, ready or willing to complete the sale in accordance with the contract.
Opening the case on Wednesday, Declan McGrath SC, for Atlas, told the court there was an “inaccuracy” in the underlying ordnance survey map provided. He said the small portion of land at issue was located within the physical boundaries of the site but was outside the conveyance map.
On Thursday, Mr Crean, under cross-examination, disagreed with DCU’s barrister, Paul Gardiner SC, that there was an alternative access route via the tree-lined Griffith Avenue.
Mr Crean said his development firm has many considerations when assessing potential access routes to a site, including traffic levels at peak times, potential blind spots on the roads, disruption to residents and the positioning of trees.
He added: “We can on paper go in and out lots of different ways ... when you get to test it then, will it work?”
Mr Gardiner suggested Mr Crean “fastened upon” the proposition that this route was essential because the sale was no longer advantageous when Covid-19 hit and the markets paused. Mr Crean did not agree with this.
“I was committed to the transaction,” he said.
The sale was originally supposed to close in January 2020, but this did not occur as DCU dealt with issues about transferring part of the lands and clarifying map issues raised by Atlas.
By the end of July 2020, the university’s chief operating officer said, Atlas complained of significant legal points and mapping queries but failed to identify what the issues were.
In August the university formally asked Atlas to complete the sale within 14 days. Atlas contended DCU was unable to sell because it did not have sufficient title to a small area that was critical to the development potential of the site.
Atlas also claims the sale was at an end due to Covid-19. DCU has refuted this and asserted that Atlas acknowledged as part of the sale conditions that it had fully investigated the title.
